5:32 PM
 | 
Dec 19, 2012
 |  BC Extra  |  Politics & Policy

ORP Director to become senior advisor with compounding focus

Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, said in an internal memo that Jane Axelrad, director of the Office of Regulatory Policy (ORP), will become...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >